Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
-
ACV Announces Participation in Upcoming Investor Conferences
-
EverQuote to Participate in Upcoming Investor Conferences
-
MediaAlpha to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Blend to Participate in The Canaccord Genuity 44th Annual Growth Conference
-
EZCORP to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Electromed, Inc. to Participate in the 2024 Canaccord Global Growth Conference
-
Neurocrine Biosciences to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Atara Biotherapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Lyft (LYFT) PT Lowered to $18 at Canaccord Genuity
-
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in a Fireside Chat at Upcoming Conference
-
Zevra Therapeutics to Present at Canaccord Genuity’s 44th Annual Growth Conference
-
Qualys to Speak at Upcoming Investor Conference
-
ZoomInfo to Participate in Upcoming Investor Conferences
-
Revolo Announces Fireside Chat at Canaccord Genuity’s 44th Annual Growth Conference
-
Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
-
Innovid to Participate in Upcoming Investor Conferences
-
Immutep to Participate in Upcoming Investor Conferences
-
ON24 to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Accolade To Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
-
Cybin to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Unisys (UIS) PT Lowered to $4.25 at Canaccord Genuity
-
Y-mAbs to Participate in Upcoming Investor Conferences in August
-
Vivid Seats Inc. (SEAT) PT Lowered to $8 at Canaccord Genuity
-
Rhythm Pharmaceuticals (RYTM) PT Lowered to $77 at Canaccord Genuity
-
BioXcel Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
-
Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
-
atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Rocket Pharmaceuticals (RCKT) PT Lowered to $38 at Canaccord Genuity
-
Qualys (QLYS) PT Lowered to $160 at Canaccord Genuity
-
Nevro Corp (NVRO) PT Lowered to $8 at Canaccord Genuity
-
Hudson Technologies (HDSN) PT Lowered to $8.75 at Canaccord Genuity
-
Eve Holding Inc. (EVEX) PT Lowered to $7 at Canaccord Genuity
-
Traeger Inc. (COOK) PT Raised to $5 at Canaccord Genuity
-
Traeger to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Canaccord Genuity Downgrades Progyny (PGNY) to Hold
-
Touchstone Exploration Inc. Announces Employee Share Purchase Plan
-
Travere Therapeutics to Present at Upcoming Investor Conferences
-
Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Standard BioTools to Participate in Upcoming Investor Conferences
-
MindMed to Present at Canaccord Genuity’s 44th Annual Growth Conference
-
Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference
-
Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Converge Technology Solutions Announces Participation in the Canaccord Genuity 44th Annual Growth Conference
-
SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024
-
NervGen Pharma to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Clover Health (CLOV) PT Raised to $2.50 at Canaccord Genuity
-
Canaccord Genuity Downgrades TELUS Corp. (T:CN) (TU) to Hold
-
Merus to Present at Canaccord Genuity’s 44th Annual Growth Conference
-
Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference

